To enhance the receptors expression, a BRIL fusion protein and an optimized maltose binding protein-maltose binding protein tag (OMBP-MBP) 54 were added to the N and C termini of the receptor to facilitate the receptor stability and expression (Supplementary Fig
However, sublingual bioavailability for peptides is inherently lower than subcutaneous injection because the oral mucosa presents a significant absorption barrier for large molecules
Available at: Continue reading [10] Bin Dayel, S., Hussein, R.S., Atia, T., Abahussein, O., Al Yahya, R.S., Elsayed, S.H
Given these practical constraints, clinicians, formulary decision-makers, and payers should use a patient-centered approach, balancing efficacy, costs, patient preferences, and safety considerations when selecting obesity pharmacotherapy